Similar Papers

Paper Title
Journal
Date
Author
Docetaxel and cyclophosphamide as adjuvant chemotherapy for early breast cancer: primary prophylaxis with G-CSF is required
Roopa Lakhanpal ... Arlene Chan
Breast Cancer Management | VOL. 2
Roopa Lakhanpal, et. al.Roopa Lakhanpal ... Arlene Chan
19 Aug 2013
A multicenter audit of the incidence of febrile neutropenia and neutropenia associated with docetaxel and cyclophosphamide (TC) chemotherapy for early breast cancer.
Roopa Lakhanpal ... Patricia A Bastick
Journal of Clinical Oncology | VOL. 31
Roopa Lakhanpal, et. al.Roopa Lakhanpal ... Patricia A Bastick
20 May 2013
Abstract PO2-12-12: REaCT 5G: A randomized study comparing bone pain after 5 days of filgrastim or one day of pegfilgrastim for primary febrile neutropenia prophylaxis during neo-/adjuvant chemotherapy for early breast cancer
Terry Ng ... John Hilton
Cancer Research | VOL. 84
Terry Ng, et. al.Terry Ng ... John Hilton
02 May 2024
The cost-effectiveness of primary prophylaxis with granulocyte colony-stimulating factor in docetaxel-containing adjuvant chemotherapy in early breast cancer: The impact of risk of febrile neutropenia and its mortality.
K K Chan ... A Eisen
Journal of Clinical Oncology | VOL. 29
K K Chan, et. al.K K Chan ... A Eisen
20 May 2011
View more papers

More From: Breast Cancer Management

Paper Title
Journal
Date
Author
The Characteristics of HER2 Low-Expressing Breast Cancer: a China Single-Center Real-World Data Analysis
Caiping Chen ... Wang Li
Breast Cancer Management | VOL. 12
Caiping Chen, et. al.Caiping Chen ... Wang Li
01 Dec 2023
Magnetic Resonance Imaging in the Preoperative Evaluation of Invasive Lobular Carcinoma; A Useful Investigation?
Ashkun Naderian ... Kowsalya Murugappan
Breast Cancer Management | VOL. 12
Ashkun Naderian, et. al.Ashkun Naderian ... Kowsalya Murugappan
01 Dec 2023
Survival Analysis of Breast Cancer in Patients with HER2/neu+, ER-, PR-: a Retrospective Cohort Study
Ebrahim Babaee ... Negin Mahmoudi Hamidabad
Breast Cancer Management | VOL. 12
Ebrahim Babaee, et. al.Ebrahim Babaee ... Negin Mahmoudi Hamidabad
01 Sep 2023
Patients with HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors: A Real-World Study in Italy
Valentina Perrone ... Melania Dovizio
Breast Cancer Management | VOL. 12
Valentina Perrone, et. al.Valentina Perrone ... Melania Dovizio
01 Jun 2023
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.